Highlights

  • FY26 gross Revenue expected to exceed $7.4m, up 27% YoY and 14% above prior guidance
  • Expansion driven by strong New Zealand retail growth + new Southeast Asia distribution deal
  • EBITDA loss projected to fall below $1.6m, improving 25% vs FY25

Overview

Me Today (NZX:MEE) has upgraded its FY26 outlook, signaling stronger-than-expected revenue momentum and improving cost efficiency. The company now anticipates gross revenue above $7.4 million, reflecting robust growth of 27% year-on-year and a meaningful uplift from earlier guidance. This performance is underpinned by accelerating Demand in New Zealand, where expanded retail shelf space and new product launches have significantly boosted sales. Internationally, the Business is entering a new phase of growth with a distribution agreement across Southeast Asia, starting with Singapore.

At the same time, disciplined cost management and operational focus are expected to reduce EBITDA losses to below $1.6 million, marking a 25% improvement on the prior year despite continued Investment in Brand and product innovation.

NZ Growth & Product Expansion Driving Momentum

The New Zealand market remains the core growth engine for Me Today, supported by stronger visibility across major retail partners following a new planogram rollout. This has directly contributed to a reported 113% increase in retail sales within its largest NZ channel. Growth is further reinforced by an aggressive product innovation strategy, with 15 new launches in FY26, including herbal liquids, capsules, sprays, and functional powder blends. The brand is also expanding into new wellness formats, strengthening its position in the competitive health supplements space.

Southeast Asia Expansion & Global Reach Strategy

Me Today has secured a key milestone with an exclusive distribution agreement across Singapore, Malaysia, Thailand, and Vietnam, marking a strategic entry into high-growth Asian wellness markets. Singapore will serve as the initial launchpad, supported by early purchase orders and regional Marketing activation. Regulatory approvals for other markets are expected through 2027, indicating a phased expansion strategy. Alongside Asia, the company continues to build presence in the US, Japan, Ireland, and the UAE, with Manuka honey-led sales in the US already exceeding NZD $1.04m in FY26.